Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 2577  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  » Next article
  » Previous article 
  » Table of Contents
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (65 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  


  In this Article
 »  Abstract
 »  Introduction
 »  Case Report
 »  Discussion
 »  References

 Article Access Statistics
    Viewed13310    
    Printed250    
    Emailed12    
    PDF Downloaded220    
    Comments [Add]    
    Cited by others 4    

Recommend this journal

   
CASE REPORT
Year : 2004  |  Volume : 52  |  Issue : 1  |  Page : 102-103

Paroxysmal kinesigenic dyskinesia manifestation of hyperthyroidism


Department of Neurology, G. B. Pant Hospital, New Delhi - 110 002

Correspondence Address:
16, Type 5, MAMC Campus, New Delhi - 110002
vpuri@bol.net.in

  »  Abstract

Sporadic paroxysmal kinesigenic dyskinesia (PKD) secondary to thyrotoxicosis is an extremely rare entity. A 36-year-old female presented with the features of PKD. Her investigations revealed thyrotoxicosis. Her dyskinesia did not respond to carbamazepine but remitted with the anti-thyroid drug, neomercazole. Perhaps hyperthyroidism-related PKD is a result of a metabolic disturbance of the basal ganglia circuits rather than a permanent and irreversible change.

How to cite this article:
Puri V, Chaudhry N. Paroxysmal kinesigenic dyskinesia manifestation of hyperthyroidism. Neurol India 2004;52:102-3


How to cite this URL:
Puri V, Chaudhry N. Paroxysmal kinesigenic dyskinesia manifestation of hyperthyroidism. Neurol India [serial online] 2004 [cited 2020 Jul 14];52:102-3. Available from: http://www.neurologyindia.com/text.asp?2004/52/1/102/6712



  »   Introduction Top


Paroxysmal kinesigenic dyskinesia (PKD) is an unusual dyskinesia often precipitated by voluntary movement and characterized by brief unilateral or bilateral chorea, choreoathetosis, ballism, or dystonic postures. It is often familial, but sporadic cases have also been reported. PKD may be secondary to diverse etiologies, including multiple sclerosis, ischemic stroke, birth injury, head injury, drug abuse, diabetes mellitus, or hypoparathyroidism, and the sites of lesion can involve the cerebral cortex, basal ganglia, thalamus, medulla, and the spinal cord. There are only three reports describing PKD related to hyperthyroidism, in the literature.[1],[2],[3] However, none till date have reported PKD with sub-clinical hyperthyroidism.
We report a case of PKD in a hyperthyroid patient in whom the involuntary movements disappeared as the patient became euthyroid.


  »   Case Report Top

A 36-year-old female presented with cramping sensations in the left hand, followed by uncontrollable jerking, predominantly in the left limbs of two years duration. Typically, the attack started with dystonic posturing of either the left hand and wrist or of the left foot and ankle, spreading proximally. Sometimes the attack became choreic and on other occasions there was ballistic movement around either the shoulder or the hip joint. Infrequently, the involuntary movements were confined to the right side only. On rare occasions the attack occurred bilaterally and made her fall. Her consciousness remained clear throughout the attack. The abnormal movements were transient in nature, lasting for 20-30 seconds, mostly triggered by sudden voluntary activities like jumping out of bed, arising quickly from the chair, running to open the door, to attend the telephone or sudden turning to look back. These attacks would occur several times in a day with variable inter-attack interval. Sometimes she did not experience any attack for 10-15 days. The attacks never occurred during sleep, nor could they be provoked after hyperventilation, startle, touch, fatigue, excitement or exercise. She denied any of her family members having similar or any other involuntary movements. She never experienced heat intolerance, palpitation, diarrhea, weight loss, or tremors.
Physical examination was non-contributory. Detailed neurological examination was essentially normal. There was no KF ring on slit-lamp examination. Both fundi were normal. Two of these attacks involving the left side could be observed. In one of these episodes she had flexion of the left wrist, hyper pronation of the left hand and abduction of the shoulder; and in another there was abduction of the hip with the foot assuming the attitude of equinovarus deformity. The episodes were stereotyped. There was no axial muscle involvement, nor any oromandibular dystonia or facial grimacing.
Her hemogram, including red cell morphology, blood chemistry for blood sugar, blood urea, serum creatine, serum electrolytes, profile for liver function, lipid, serum copper, ceruloplasmin, serum calcium, phosphorus, and parathormone level were normal. Collagen profile for rheumatoid factor, ds.DNA, antinuclear factor were normal. Serum free triiodothyronine was 6.7pg/ml (normal range 2.3-4.2 pg/ml), free thyroxine 3.8 ng/dl (normal range 0.89-1.8 ng/dl), thyroid-stimulating hormone was 0.15 Iu/ml (normal range 0.35-5.5 Iu/ml). MR brain was normal. EEG did not show any epileptiform discharge.
She was put on carbamazepine 300 mg in three divided doses, gradually increased to 1200 mgm /day along with neomercazole 30 mg in divided doses. The patient did not show any response initially. However, she responded three weeks after the initiation of the medication and became euthyroid after about three months. The carbamazepine was gradually withdrawn and she never experienced the attacks after its withdrawal. The attacks, however, recurred four months after the withdrawal of neomercazole. Neomercazole was restarted and she has been asymptomatic on 20 mg/day of neomercazole for the last one year.


  »   Discussion Top


Neurological manifestations of thyrotoxicosis are not uncommon. However, chorea or choreoathetosis occur rarely with thyrotoxicosis. The movement disorder usually resolves completely with the use of anti-thyroid medications and recurs if hyperthyroidism redevelops.[4],[5],[6] The present case had the features of PKD which was unresponsive to the treatment with carbamazepine but disappeared when the levels of thyroid hormones returned to normal, and recurred after the withdrawal of neomercazole. The involuntary movements in the present case as well as in the previous reports[1],[2],[3] were characterized by prominent dystonic posturing of the limb at the beginning of the attacks and were induced by voluntary movements.
Acquired choreoathetosis has been described in a number of diseases, including hypocalcemia, systemic lupus erythematosus, Schonlein-Henoch purpura, polycythemia, carbon monoxide poisoning, thromboembolism of the posterior cerebral artery and post viral encephalitis.
The clinical profile of the present case was not consistent with any of these disorders.
Besides the induction of PKD, several reports have mentioned the association of hyperthyroidism with the occurrence of chorea.[7],[8] All the previous three reports of PKD with hyperthyroidism had obvious thyrotoxicosis. It has been reported by Drake that PKD may occur when the patient has only mildly elevated levels of thyroid hormones.[2] The present case did not have clinically evident thyrotoxicosis. Chorea is not always associated with obvious thyrotoxicosis.[8] Evolution of choreoathetosis to chorea has been suggested to be associated with idiopathic basal ganglia calcifications.[9] Hyperthyroidism-related PKD or chorea may also share a similar mechanism.[3]
The exact mechanism of how thyroid hormones induce paroxysmal dyskinesia is not clear. Functional hypersensitivity of dopaminergic receptors in the striatum may be responsible for hyperthyroid chorea.[10] Positron emission tomographic studies are usually normal in patients with idiopathic PKD. However, decreased striatal glucose metabolism was observed in most patients with symptomatic chorea,[11] suggesting a pathogenetic mechanism different from that of idiopathic PKD. The present case had no structural lesion on neuroimaging as also in the other three reports.[1],[2],[3] It can be postulated that hyperthyroidism-related PKD is more likely the result of a metabolic disturbance of the basal ganglia circuits rather than a permanent and irreversible change.
Thus, the present case is unique with PKD as the presenting manifestation of sub-clinical thyrotoxicosis. 

  »   References Top

1.Fischbeck KH, Layzer RB. Paroxysmal choreoathetosis associated with thyrotoxicosis. Ann Neurol 1979;6:453-4.   Back to cited text no. 1  [PUBMED]  
2.Drake ME Jr. Paroxysmal kinesigenic choreoathetosis in hyperthyroidism. Postgrad Med J 1987;63:1089-90.  Back to cited text no. 2  [PUBMED]  
3.Yen DJ, Shan DE, Lu SR. Hyperthyroidism presenting as recurrent short paroxysmal kinesigenic dyskinesia. Mov Disord 1998;13:361-3.   Back to cited text no. 3    
4.Dhar SK, Nair CP. Choreoathetosis and thyrotoxicosis. Ann Intern Med 1974;80:426-7.   Back to cited text no. 4  [PUBMED]  
5.Heffron W, Eaton RP. Thyrotoxicosis presenting as choreoathetosis. Ann Intern Med 1970;73:425-8.   Back to cited text no. 5  [PUBMED]  
6.Fidler SM, O'Rourke RA, Buchsbaum HW. Choreoathetosis as a manifestation of thyrotoxicosis. Neurology 1971;21:55-7.   Back to cited text no. 6  [PUBMED]  
7.Delwaide PJ, Schoenen J. Hyperthyroidism as a cause of persistent choreic movements. Acta Neurol Scand 1978;58:309-12.   Back to cited text no. 7  [PUBMED]  
8.Van Uitert RL, Russakoff LM. Hyperthyroid chorea mimicking psychiatric disease. Am J Psychiatry 1979;136:1208-10.   Back to cited text no. 8  [PUBMED]  
9.Klein C, Vieregge P, Kompf D. Paroxysmal choreoathetosis in a patient with idiopathic basal ganglia calcification, chorea, and dystonia. Mov Disord 1997;12:254-5.  Back to cited text no. 9  [PUBMED]  
10.Weiner W, Klawans H. Hyperthyroid chorea. In: Vinken P, Bruyn G, editors. Handbook of Clinical Neurology. North Holland, New York: 1976. Vol 27. pp. 279.  Back to cited text no. 10    
11.Otsuka M, Ichiya Y, Kuwabara Y, Hosokawa S, Sasaki M, Fukumura T, et al. Cerebral glucose metabolism and striatal 18F-pa uptake by PET in cases of chorea with or without dementia. J Neurol Sci 1993;115:153-7.  Back to cited text no. 11    

 

Top
Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow